Meng Zhaoling, Kringle Robert, Chen Xun, Zhao Peng-Liang
Biostatistics and Programming, Sanofi-Aventis, Bridgewater, New Jersey, USA.
J Biopharm Stat. 2010 May;20(3):563-77. doi: 10.1080/10543400903582000.
The sample size requirement in a thorough QT/QTc study is discussed under a balanced parallel or crossover study design. First, we explore the impacts of various factors on the study power, including the mean effect profile across time and correlation among time points. Then we estimate the variability parameters needed based on multiple historical studies. Different baseline usage is illustrated to have a significant impact on the analysis variability in the parallel studies. Finally, the sample size calculations and recommendations are given for demonstrating a "negative" drug effect and the study assay sensitivity, respectively.
在平衡平行或交叉研究设计下,讨论了全面QT/QTc研究中的样本量要求。首先,我们探讨各种因素对研究效能的影响,包括随时间的平均效应概况以及各时间点之间的相关性。然后,我们根据多项既往研究估计所需的变异性参数。结果表明,不同的基线用药情况对平行研究中的分析变异性有显著影响。最后,分别给出了证明“阴性”药物效应和研究分析灵敏度的样本量计算方法及建议。